Skip to main

ReShape Lifesciences

RSLS is nowHIND
RSLS logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More
Go to the new stock page

Frequently Asked Questions (FAQ)

As of Sep 22, 2025, the market cap for RSLS stock is $3.9M

The current P/E ratio for RSLS stock is -0.01

The 52-week high for RSLS stock is $749. The current RSLS stock price $undefined is 100.00% below its 52-week high

The 52-week low for RSLS stock is $5.75. The current RSLS stock price $undefined has increased 100.00% from its 52-week low

No, the RSLS stock does not pay dividends to its shareholders

The target price for RSLS stock is $6.32 based on the average of what a group of analyst think RSLS stock could be worth at a future date. This is not a prediction by Public.com

How to buy RSLS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in RSLS stock

    Navigate to the Explore page. Then, type RSLS into the search bar. When you see RSLS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased RSLS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

ReShape Lifesciences Stock Earnings

The value each RSLS share was expected to gain vs. the value that each RSLS share actually gained.

ReShape Lifesciences (RSLS) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, ReShape Lifesciences's earnings per share (EPS) was $0. ReShape Lifesciences is expected to release next earnings on 08/13/2020, with an earnings per share (EPS) estimate of $0.

Buy ReShape Lifesciences (RSLS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.